Lantern Pharma Inc. Debt Instrument, Face Amount
Lantern Pharma Inc. (LTRN) had Debt Instrument, Face Amount of $109.00 thousand as of 2021-12-31, per its 10-K filed 2023-03-20.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2023-03-20
- 2021-12-31: Debt Instrument, Face Amount $109.00K.
- 2020-12-31: Debt Instrument, Face Amount $103.00K.
- 2020-09-30: Debt Instrument, Face Amount $103.00K.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2021-12-31 | $109.00K 10-K · filed 2023-03-20 |
| 2020-12-31 | $103.00K 10-K · filed 2021-03-10 |
| 2020-09-30 | $103.00K 10-Q · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |